How does a drug's elimination half‑life determine the appropriate dosing interval, and when should dosing be three times daily, twice daily, or administered as a continuous infusion?

How Drug Half-Life Determines Dosing Intervals

A drug's elimination half-life directly determines the dosing interval by controlling how quickly drug concentrations decline between doses, with drugs requiring dosing intervals of approximately 1-2 half-lives to maintain therapeutic levels while minimizing accumulation and toxicity risk.

The Core Principle: Half-Life Controls Accumulation and Fluctuation

The elimination half-life is the time required for plasma drug concentration to fall by 50% 1, 2. This parameter fundamentally controls:

• Drug accumulation during repeated dosing
• Peak-to-trough fluctuation at steady state
• Time to steady state (achieved after 4-5 half-lives)
• Time to complete elimination after discontinuation 1, 2

The general rule: dosing intervals should equal 1-2 half-lives to balance efficacy and safety 3. Drugs with half-lives of 12-48 hours are ideal for once-daily dosing 3.

Practical Dosing Interval Selection

TID (Three Times Daily) Dosing

Use when the drug has a short half-life of 4-8 hours:

• Morphine (half-life ~2-4 hours) requires every 4-hour dosing when given intermittently 4
• Short half-life drugs need frequent dosing to avoid subtherapeutic troughs and excessive peaks 1
• Pitfall: Short half-life drugs carry higher risk of withdrawal/discontinuation syndromes between doses 1

BD (Twice Daily) Dosing

Use when the drug has a moderate half-life of 8-24 hours:

• Methadone (longer half-life) can be dosed every 12 hours initially, then transitioned to once daily 4
• Lorazepam (sixfold longer half-life than midazolam) allows every 12-hour dosing 4
• This interval provides stable therapeutic levels with acceptable fluctuation 3

Once Daily Dosing

Optimal for drugs with half-lives of 12-48 hours 3:

• Provides best patient compliance
• Minimizes peak-to-trough fluctuation
• Reduces pill burden

When to Use Continuous Infusion

Choose continuous infusion over intermittent dosing when:

1. Very short half-life drugs (e.g., fentanyl, midazolam) require constant therapeutic levels

   • Fentanyl has rapid onset (1-2 minutes) and short duration (30-60 minutes) 5
   • Continuous infusion eliminates the peaks and troughs that occur with bolus dosing

2. Critical need for stable drug levels without fluctuation

   • Critically ill patients requiring sedation/analgesia
   • Drugs with narrow therapeutic indices where peaks cause toxicity

3. Prolonged exposure >7 days is anticipated 4

   • The guidelines specifically address conversion protocols for continuous infusions lasting >7 days
   • This duration creates drug dependency requiring structured weaning

The Half-Life Correction Factor in Practice

When converting from continuous infusion to intermittent dosing, you must apply a correction factor based on the half-life difference 4:

Example: Fentanyl to Morphine Conversion

• Calculate 24-hour fentanyl dose
• Multiply by 60 (potency ratio)
• Divide by 4 (correcting for morphine's longer half-life)
• Give in 6 divided doses every 4 hours 4

Example: Midazolam to Lorazepam Conversion

• Calculate 24-hour midazolam dose
• Divide by 12 (accounting for lorazepam being 2× more potent AND having 6× longer half-life)
• Give every 6 hours initially 4

This correction prevents overdosing when switching to a longer half-life drug that will accumulate more with repeated dosing.

Critical Caveats

Flip-Flop Pharmacokinetics

When absorption is slower than elimination, the apparent half-life reflects absorption rate, not elimination 2. Extended-release formulations exploit this to allow less frequent dosing despite short elimination half-lives 6.

Special Populations Alter Half-Life

• Elderly patients: Reduced clearance prolongs half-life; reduce doses by ≥50% 5
• Renal impairment: Dramatically prolongs half-life of renally eliminated drugs (e.g., cefepime half-life increases from 2 hours to much longer) 7
• Hepatic disease: Affects drugs with hepatic metabolism
• Neonates/infants: Altered protein binding and clearance 4

The 10-15 Minute Redistribution Phase

For drugs like lidocaine, the rapid α-distribution phase (10-15 minutes) allows repeat dosing after one elimination half-life rather than waiting for complete elimination 8. This is why you can give additional doses sooner than the terminal half-life would suggest.

Steady State Timing

• Steady state is reached after 4-5 half-lives 1
• Loading doses can achieve therapeutic levels immediately but must account for eventual accumulation
• For drugs with very long half-lives, this creates challenges in clinical trial design and adverse effect management 3

The Bottom Line Algorithm

For selecting dosing intervals:

1. Half-life <4 hours → Consider continuous infusion or TID dosing
2. Half-life 4-8 hours → TID dosing
3. Half-life 8-24 hours → BD dosing
4. Half-life 12-48 hours → Once daily dosing
5. Half-life >48 hours → May require less frequent dosing but monitor for prolonged accumulation

Switch to continuous infusion when:

• Intermittent dosing creates unacceptable peaks/troughs
• Patient requires constant sedation/analgesia
• Drug has very short half-life (<2 hours) and narrow therapeutic index